Context Therapeutics Inc. (CNTX) stock

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.18−0.02 (-8.69%)

Close on Nov 13, 2026Market cap $16.61MP/E –Yield –

Context Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Context Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?